Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



LESCHLY MARK Create: Alert

All | News | Filings
Date FiledTypeDescription
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2022 4 LESCHLY MARK (Director) has filed a Form 4 on ChargePoint Holdings, Inc.
Txns: Granted 13,563 shares @ $0
07/14/2021 4 LESCHLY MARK (Director) has filed a Form 4 on ChargePoint Holdings, Inc.
Txns: Granted 3,192 shares @ $0
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
05/22/2020 4 LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 16,806 options to buy @ $20.37, valued at $342.3k
05/17/2019 4 LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Granted 24,000 options to buy @ $13.35, valued at $320.4k
04/10/2019 4 LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC
Txns: Converted 3,766,667 shares @ $0
Converted 3,000,000 preferred shares @ $0
Converted 600,000 preferred shares @ $0
Converted 166,667 preferred shares @ $0
04/03/2019 3 LESCHLY MARK (Director) has filed a Form 3 on NGM BIOPHARMACEUTICALS INC
04/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/24/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/18/2016 4 RHO Ventures VI LP (10% Owner) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Bought 152,273 shares @ $4.7798, valued at $727.8k
Bought 247,727 shares @ $4.9303, valued at $1.2M
09/16/2015 4 RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.
Txns: Sold 22,107 shares @ $9.4862, valued at $209.7k
Sold 11,793 shares @ $9.3439, valued at $110.2k
09/14/2015 4 RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.
Txns: Sold 27,500 shares @ $9.5351, valued at $262.2k
Sold 17,333 shares @ $9.4927, valued at $164.5k
09/01/2015 4 RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.
Txns: Sold 20,689 shares @ $10.6412, valued at $220.2k
Sold 57,595 shares @ $10.3198, valued at $594.4k
Sold 42,983 shares @ $9.9655, valued at $428.3k
06/11/2015 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 794 shares @ $0
Granted 4,096 options to buy @ $69.4, valued at $284.3k
02/25/2015 4 RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
Txns: Converted 1,606,230 shares @ $0
Converted 73,092 shares @ $0
Bought 958,226 shares @ $6, valued at $5.7M
Converted 5,128,577 options to buy @ $0
Converted 432,591 convertible notes @ $0
01/06/2015 4 Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc.
Txns: Sold 88,000 shares @ $10.8319, valued at $953.2k
Sold 164,919 shares @ $10.5389, valued at $1.7M
Sold 20,941 shares @ $9.9011, valued at $207.3k
08/29/2014 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Sold 13,067 shares @ $22.5, valued at $294k
06/06/2014 4/A LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Acquired 13,067 shares @ $0
05/30/2014 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $14.22, valued at $213.3k
04/03/2014 4 Rho Capital Partners LLC (10% Owner) has filed a Form 4 on Everyday Health, Inc.
Txns: Converted 4,554,808 shares @ $0
Sold 92,120 shares @ $13.02, valued at $1.2M
Converted 1,341,057 preferred shares @ $0
Converted 1,646,948 preferred shares @ $0
Converted 384,874 preferred shares @ $0
Converted 393,060 preferred shares @ $0
Converted 1,970,210 preferred shares @ $0
Converted 861,110 preferred shares @ $0
02/19/2014 4 Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc.
Txns: Converted 942,455 shares @ $0
Converted 203,374 shares @ $0
Granted 180,997 shares @ $0
Converted 5,631,531 preferred shares @ $0
Converted 494,447 preferred shares @ $0
Converted 1,215,268 convertible notes @ $0
Converted 106,697 convertible notes @ $0
Converted 1,215,268 preferred shares @ $0
Converted 106,697 preferred shares @ $0
02/05/2014 4 RHO Ventures VI LP (10% Owner) has filed a Form 4 on Cara Therapeutics, Inc.
Txns: Converted 2,442,239 shares @ $0
Bought 225,818 shares @ $11, valued at $2.5M
Converted 6,105,598 preferred shares @ $0
06/07/2013 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $5.11, valued at $76.7k
05/28/2013 4 RHO Ventures VI LP (10% Owner) has filed a Form 4 on BLUEFLY INC
Txns: Sold 11,900,164 shares @ $0.0076, valued at $90.4k
Disposed of 1,875 shares @ $0
Disposed of options to buy @ $1500000, valued at $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy